The new book “For Blood and Money” shows how two drugs bought for as little as $1,000 turned into multi-billion dollar blockbusters that made a difference for cancer patients.
Richard Miller was the cofounder and CEO of Pharmacyclics, a small biotechnology company in Silicon Valley with a stock that had plunged. The company’s big study to test its lead drug candidate in patients with different kinds of cancer that spread to the brain had failed miserably. He had talked to...